FluxAI ENTERPRISE
Competitive Intelligence Tracker
Monitor research activity and strategic directions across organizations
AI Research Assistant
What competitive intelligence would you like to analyze today?
Organization Research Focus
Focus Areas:
AI Insight:
NeuroCorp has shifted 40% of research from general neurology to Alzheimer's disease in the past 6 months, suggesting a strategic pivot.
Research Velocity
Researcher Network
Network visualization loading...
Dr. Robert Chen
Stanford University
AI Analysis:
Recent shift to CAR-T cell therapy research suggests alignment with Novartis strategic direction.
Patent Activity
New patents (last 30 days)
vs previous period
Top Patent Categories
Collaboration Patterns
Emerging Collaborations
Roche + Oxford University
New joint lab for AI-driven drug discovery
Pfizer + Mayo Clinic
Expanded partnership on digital biomarkers
Novartis + MIT
$25M funding for biomaterials research
Collaboration Strength
AI Pattern Recognition
Cross-sector collaborations in immunotherapy have increased by 35% in the last quarter, with most partnerships focusing on combination approaches that pair targeted therapies with checkpoint inhibitors.
Strategic Direction Predictor
AI-Powered Prediction
Based on 3,421 research papers, 856 patents, and funding data
Predicted to shift focus toward cell therapy manufacturing solutions within 6-12 months based on patent activity and talent acquisition patterns.
Research pattern suggests major investments in liquid biopsy technology for early cancer detection, with likely announcement of clinical trials in Q3.
Publication pattern indicates renewed focus on antibiotic resistance with potential expansion of antimicrobial research division.